Latest Receptor Stories
Structures of human P2Y1 receptor bring new excitement to GPCR research BEIJING, March 30, 2015 /PRNewswire/ -- A team of Chinese and US scientists has determined the high-resolution
International Collaboration's initial focus is to solve 3D structures of significant drug targets for diabetes, cancer and mental disorders LOS ANGELES and SHANGHAI, Feb.
LONDON and BOSTON, January 23, 2015 /PRNewswire/ -- Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, is delighted
LONDON and BOSTON, January 22, 2015 /PRNewswire/ -- Stable Receptor, X-ray Structure and Hit Series Generated for PAR2, a Previously
WELWYN GARDEN CITY, England and BOSTON, January 6, 2015 /PRNewswire/ -- Heptares Therapeutics, the clinical-stage GPCR drug discovery and development company, notes that
LONDON and BOSTON, December 15, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, is pleased to announce
LONDON and BOSTON, November 20, 2014 /PRNewswire/ -- Project to develop first-in-class selective and orally available GLP-1 receptor antagonist for treating severe
LONDON and BOSTON, November 17, 2014 /PRNewswire/ -- Program to be presented at Therapeutic Area Partnerships Conference in
-Discovery of Novel Investigational Drug Candidates that Interact with sigma-2/PGRMC1 Receptor Offer Potential to Stop and Reverse Memory Loss in Alzheimer's Patients - PITTSBURGH,
ChanTest announces development of newly validated and re-engineered cells to support a critical element of the drug discovery process for the biopharmaceutical industry. Cleveland,
- A handkerchief.
- In general, any miraculous portrait of Christ.